iiinova — where your digital self keeps evolving

Gísli @ipfdoc.bsky.social · 03/05/2026

I may be biased, but what a worthy winner of this award. @kerrijohannson.bsky.social commitment to improving care & quality of life for patients with respiratory disease is second to none! She is an inspiration to the community! 👏👏👏👏 Kerri

250

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 17/04/2026

Dr. Veronica Marcoux presents official Canadian Thoracic Society position statement “Infection screening before starting immunosuppression in interstitial lung disease” 🫁 Addressing MTB, HIV, HBV, HCV & strongyloides @veronicasam940.bsky.social 👏 #OpenAccess www.tandfonline.com/doi/full/10....

Dr Marcoux at podium with slide in background

Summary of recommendations from the paper

295

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 17/04/2026

Older men with a microphone 🎤 Stop pointing out how many women are speaking at a conference. It’s not novel or noteworthy. It should be standard in 2026.

071

Reposted by Gísli

KaminskiMed @kaminskimed.bsky.social · 18/04/2026

The scientific news Antivexers in our gov do not want you to see. Maternal RSV vax protects of newborn infants‼️ Great to see a gov health agency doing its job without being harassed by charlatans, grifters, eugenicists. 👏🏼UKHSA👏🏼 #VaccinesWork www.gov.uk/government/n...

052

Reposted by Gísli

American Thoracic Society (ATS) @atscommunity.bsky.social · 18/04/2026

Check out the American Thoracic Society at #CRC2026! ❤️🇨🇦 Irina Petrache, MD, ATSF, immediate-past president of the ATS, presented on international perspectives, and along with ATS CEO Karen Collishaw, MPP, connected with leaders in health care and respiratory medicine from around the world.

132

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 08/04/2026

Have you ever wanted to write an official ATS clinical practice guideline or technical statement or workshop report but didn’t know where to start? Then THIS podcast is for you! 🤩 Just out from @ats-clinicalprobs.bsky.social @ats-assemblies.bsky.social youtu.be/7DIJRdQDu2o?...

youtu.be

How to Develop Your ATS Document Proposal

YouTube video by American Thoracic Society

011

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 08/04/2026

The most impactful clinical ILD study in ages! 🌟 True multidisciplinary collaboration driving progress 🫁 @rogerjlewis.bsky.social @ipfdoc.bsky.social A Statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic ILD academic.oup.com/ajrccm/advan... #OpenAccess

022

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 16/03/2026

I thought he was playing golf?

062

Reposted by Gísli

ATSScholar @atsscholar.bsky.social · 20/01/2026

Multidisciplinary Videoconferencing for Physician Education and Remote Management of Interstitial Lung Disease @atscommunity.bsky.social #medsky 🔗 tinyurl.com/2cjt69hv

033

Gísli @ipfdoc.bsky.social · 03/03/2026

I wonder how much of my life has been wasted resetting passwords! 😫😫

010

Gísli @ipfdoc.bsky.social · 21/12/2025

www.rollingstone.com/culture/cult... Is this the unavoidable endpoint when knowledge, ego and career converge? This is a chilling article which clearly needs the academic community to find a solution, but we need to rethink how we reward academic endeavour. #NoMorePublishOrPerish

rollingstone.com

AI Is Inventing Academic Papers That Don't Exist -- And They're Being Cited in Real Journals

Academic articles from authors using large language model are creating an ecosystem of fake research that threatens human knowledge itself.

142

Gísli @ipfdoc.bsky.social · 27/11/2025

Would be lovely to get your perspective.

100

Gísli @ipfdoc.bsky.social · 29/10/2025

The most exciting papers of the year! Could these observers provide insights into the potential of immunotherapy in other conditions? 🤔

010

Gísli @ipfdoc.bsky.social · 15/10/2025

This is a really great thread 🧵 about an important study using mixed methodology to understand a subject that rarely gets the attention it deserves. Kudos to the team @ucalgary.bsky.social guided by the brilliant @kerrijohannson.bsky.social

020

Gísli @ipfdoc.bsky.social · 28/09/2025

TETON-2 data looking good! 96ml of FVC ‘saved’ by inhaled treprostinil at 12 months. Devil will be in detail but all very promising.

152

Gísli @ipfdoc.bsky.social · 26/09/2025

youtu.be/zTs3PDEkB2w Interesting story. 1) Brexit actually increased migration. 2) Students r source of UKs immigration‘problem’, likely due to our outstanding universities 3) Cumulative asylum seeker retention builds up 4) A ‘hostile environment’ might work but at what cost & for what impact? 😬

youtu.be

UK immigration: What the numbers really show

YouTube video by Sky News

020

Gísli @ipfdoc.bsky.social · 08/09/2025

Pogacar vs Vingegaard? Alcaraz vs Sinner? Tottenham vs Arsenal? Giants vs Dodgers? Nemesis vs motivation?

010

Gísli @ipfdoc.bsky.social · 07/09/2025

I think this is a great idea, might be tricky to operationalise. The current system is breaking if not already broken. Incentivises research fraud. Will prevent people seeing the wood because of all the dodgy trees. #LessIsMore

011

Gísli @ipfdoc.bsky.social · 04/09/2025

This makes me sad (not altogether sure why), but I would like thank #DanielLevy for his hard work over last 25 yrs. The Stadium, European Glory Nights, Great teams, superstar players! 😍 There were some lows I’m sure but I don’t remember those. #COYS

030

Gísli @ipfdoc.bsky.social · 02/09/2025

Phenomenal result! FIRST positive 52 week study of inhaled therapy in #IPF. Benefits were independent of background therapy! 🤩 Along with Nerandomilast this shows importance of cAMP/PDE4 pathways in fibrosis & opens door 4 other therapies targeting these pathways! #FutureLooksBright #CureIPF

033

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 02/09/2025

TETON-2 phase 2 RCT of nebulized treprostinil for IPF 🫁 Positive trial 🗞️ Change in FVC at 52 weeks difference of 95.6mL (!), and 2* endpoints like K-BILD @ipfdoc.bsky.social @kaminskimed.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social www.theglobeandmail.com/investing/ma...

174

Gísli @ipfdoc.bsky.social · 08/08/2025

I think there is no clinical need to update the classification, and I just can’t wait for the next update! 🥱

111

Gísli @ipfdoc.bsky.social · 08/08/2025

I’ve just been struck by how structurally (if not functionally) similar broccoli 🥦 is to the lungs 🫁! 😍🤣

110

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 23/07/2025

This isn’t about Republicans or Democrats or anything to do with politics This is about men exploiting and committing sexual violence against women and girls THIS is the issue to bring to the forefront address

051

Reposted by Gísli

Waggoner Lab @labwaggoner.bsky.social · 22/07/2025

People’s brains aged faster during the COVID pandemic — even the uninfected @nature.com www.nature.com/articles/d41... @natcomms.nature.com @alirezamnk.bsky.social @spmic-uon.bsky.social @ipfdoc.bsky.social www.nature.com/articles/s41...

174

Reposted by Gísli

Carl T. Bergstrom @carlbergstrom.com · 16/07/2025

1. Kevin Gross and I just posted a new science-of-science preprint. This one explores the looming peer review crisis. As many of you know, it's becoming significantly more difficult for journal editors to find scholars willing to serve as peer reviewers for submitted manuscripts.

arxiv.org

Will anyone review this paper? Screening, sorting, and the feedback cycles that imperil peer review

Scholarly publishing relies on peer review to identify the best science. Yet finding willing and qualified reviewers to evaluate manuscripts has become an increasingly challenging task, possibly even ...

22561221

Reposted by Gísli

Annals of the ATS @annalsats.bsky.social · 16/07/2025

Incidence, Prevalence & Mortality of ILDs in Alberta, Canada Derived, tested case definitions performed well, created a dataset of ILD. Incidence was stable, prevalence increased, mortality decreased for ILD & IPF sub-group @kerrijohannson.bsky.social @agrantorser.bsky.social tinyurl.com/5n7x5w2h

262

Gísli @ipfdoc.bsky.social · 13/07/2025

Great article from @theguardian.com which nicely summarises a real problem. As I’m fond of saying ‘if you are looking for a needle in a haystack, stop adding more hay!’ Thanks for sharing @kerrijohannson.bsky.social @bmj.com

111

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 13/07/2025

Tips for academic sustainability: Only review for journals you know Do not submit to predatory journals Do NOT contribute to this crap Stop thinking about 'getting papers' and think about 'advancing your field' - this needs to change for promotion and merit www.theguardian.com/science/2025...

theguardian.com

Quality of scientific papers questioned as academics ‘overwhelmed’ by the millions published

Widespread mockery of AI-generated rat with giant penis in one paper brings problem to public attention

3134

Gísli @ipfdoc.bsky.social · 10/07/2025

How many people ask permission from proposed reviewer when they ‘recommend’ a reviewer for submitted publication? Fairly standard when requesting professional reference and might reduced the number of declined reviews from ‘recommended reviewers’? #AnswersOnAPostcard

110

Gísli @ipfdoc.bsky.social · 08/07/2025

NEWSFLASH, any reviewer for BMJOpenRespRes gets a 25% discount on the APC for manuscripts submitted to BMJOpenRespRes within 12 months. There maybe further positive moves in future #SmallSteps. #GettingThere 🙏🙏

173

Gísli @ipfdoc.bsky.social · 05/07/2025

Wow! 🤩 Some really important messages in here! The burden of ILD is higher than thought AND rising. Burden in rural communities higher than cities! 🤔?🌾🚜🐤 Mortality 📉 suggests Dx and Mx improving 🥳 Kudos to @kerrijohannson.bsky.social & team!

111

Reposted by Gísli

KaminskiMed @kaminskimed.bsky.social · 04/07/2025

Important! A population based study of trends in incidence, prevalence, mortality of ILD over 10 yrs. Good news: Mortality ⬇️. Expected news: Incidence unchanged, Prevalence ⬆️ Important News: there are a lot of ILD patients 👏🏼 Drs Johannson, Fisher & team!!! www.atsjournals.org/doi/full/10....

atsjournals.org

Incidence, Prevalence, and Mortality of Interstitial Lung Diseases in Alberta, Canada: A Population-based Study | Annals of the American Thoracic Society

Rationale: The epidemiology of adult interstitial lung disease (ILD) is uncertain, given heterogeneous estimates from prior studies.

0163

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 04/07/2025

Kudos to the amazing team from University of Calgary Centre for Health Informatics, support from the AB ILD UHF grant (without whom this would not be possible), and collaborators including @agrantorser.bsky.social Dr. Jolene Fisher & @annalsats.bsky.social for appreciating the value of this work 💪🫁😊

media.tenor.com

a blue and white penguin says thank you

ALT: a blue and white penguin says thank you

152

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 04/07/2025

Incidence, Prevalence, and Mortality of Interstitial Lung Diseases in Alberta, Canada: A Population-based Study www.atsjournals.org/doi/suppl/10... 🧵👇 📣 TL:DR Incidence stable, prevalence rising, improved survival for ILD & IPF over 10 years. Numbers much higher than prior reports for ILD & IPF.

Screenshot of title of study and authorship

2299

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 24/06/2025

Peer review as it’s currently done is baloney and often meaningless. Keep in mind I don’t publish in Science or Nature. The whole process of knowledge dissemination needs an overhaul and redefining of metrics.

093

Reposted by Gísli

Dr Amanda Tatler @amandatatler.bsky.social · 24/06/2025

I just stepped down from editorial board of a Nature subsidiary journal. Sending 300 invites to get 2 accept is soul-destroying. And I wasn’t paid as an editor for handling 10 papers at a time never mind the reviewers! #pay4peerreview

171

Gísli @ipfdoc.bsky.social · 24/06/2025

🤣🤣🤣🤣🤣🤣

000

Gísli @ipfdoc.bsky.social · 24/06/2025

It’s a practical question not a philosophical one. If the choice is wait many months while AEs try & fail to get reviews or get your manuscript back for resubmission elsewhere which is an authors preference?

210

Gísli @ipfdoc.bsky.social · 24/06/2025

We can’t desk accept because by definition it’s not been peer reviewed. Therefore, the journal would no longer ‘a peer reviewed journal’ which is criterion for most academic promotions, grants etc. In which case people might as ell deposit on their institutional website only.

120

Gísli @ipfdoc.bsky.social · 23/06/2025

Question for the #Medicine #Science community about peer review in the context of time to decision. Would people prefer a limit on review declines before an automatic desk reject? Eg 10 reviewers decline manuscripts auto rejected, or keep on trying? Like 4 auto reject Repost 4 keep on trying

130

Gísli @ipfdoc.bsky.social · 18/06/2025

Hopefully other journals will up their game soon 🙏Maybe AI will help? @bmj.com

000

Gísli @ipfdoc.bsky.social · 18/06/2025

Agee. Quality not easily measured by IF but should be the driving factor with good & fair service provided to authors. There is a lot of work to be done to reach this standard! 😔 #WillKeepTrying

111

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 18/06/2025

I’ll be perfectly honest. I couldn’t care less about IF. All I want is for my work to handled appropriately, in unbiased fashion, and published in journals with analogous quality work. This is what all these journals should be striving for, and frankly there’s a lot of work to be done for most.

021